NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

Dlogic, what are the chances of financial viability for the company if the L trial goes up in flames? Will they have the ability to raise the hundreds of millions necessary to fund large Phase 2 multi center Direct trials targeting many different cancers and simultaneously develop a fully automated closed loop manufacturing system on multiple continents?

What would this magnitude of dilution do to current and prospective shareholders when considering the available/offered terms of financing for the last two capital raises and the current share price?

When looking at the last 15 years of development and clinical testing for the L platform, and the 3 + years already on the books for the Direct Phase 1 safety evaluation, how long are we realistically looking at for Direct to reach commercialization?

Considering the previous 1 for 15 and 1 for 16 reverse splits and the current share price, what would you tell someone looking to invest in the company at this point in time? What would you say to an investor who put down $10,000 pre 2007 who's investment today is worth about $120 and who thought the Phase 3 trial would be completed long ago but has experienced delay after delay while the management team continues to collect hundreds of thousands of dollars per year with no sense of urgency to complete anything?

What would you tell someone looking at a 10 year chart of the stock?

Thanks in advance.